tranexamic acid has been researched along with Amyloidosis, Familial in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Amyloidosis, Familial: Diseases in which there is a familial pattern of AMYLOIDOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both treatments considered safe for MA." | 3.11 | Comparison of the efficacy and safety of intralesional injection of tranexamic acid and the topical application of Kligman combination drug in the treatment of macular amyloidosis. ( Ghassemi, M; Goodarzi, A; Kamani, SA; Roohaninasab, M; Sadeghzadeh-Bazargan, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghassemi, M | 1 |
| Roohaninasab, M | 1 |
| Kamani, SA | 1 |
| Sadeghzadeh-Bazargan, A | 1 |
| Goodarzi, A | 1 |
1 trial available for tranexamic acid and Amyloidosis, Familial
| Article | Year |
|---|---|
Comparison of the efficacy and safety of intralesional injection of tranexamic acid and the topical application of Kligman combination drug in the treatment of macular amyloidosis.
Topics: Administration, Topical; Amyloidosis, Familial; Humans; Hyperpigmentation; Injections, Intralesional | 2022 |